haematology anaesthesia surgery
Red Cell Transfusion Threshold Assessment
Guides red cell transfusion decisions using restrictive vs liberal threshold based on clinical context. NICE/BCSH 2015.
References
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Voxelotor · Haemoglobin S Polymerisation Inhibitor — Sickle Cell Disease
- Sodium Cromoglicate Nasal Spray · Mast Cell Stabiliser — Allergic Rhinitis
- Olopatadine · H1 antihistamine + mast cell stabiliser
- Hydroxycarbamide (Hydroxyurea) · Cytoreductive agent / Sickle cell disease / CML
- Rituximab (Haematology) · Anti-CD20 Monoclonal Antibody
- Crizanlizumab · P-selectin Inhibitor — Sickle Cell Disease
Pathways
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Anaemia Investigation · BSH / NICE
- Splenomegaly Workup · BSH; BMJ Best Practice
- Deep Vein Thrombosis Diagnosis and Treatment · NICE CG144 / NICE NG158
- Sickle Cell Crisis · BSH 2021 / BCSH
- Neutropenic Sepsis · NICE CG151 2012 / ESMO
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.